February 21, 2007 – InSightec’s ExAblate 2000, a Magnetic Resonance Imaging (MRI) focused ultrasound device that treats uterine fibroid tumors, is now allowing most patients to find relief within three months of treatment and to return to work within days.
The ExAblate 2000 uses a combination of ultrasound waves and MRIs to image, treat and ablate soft tissue. Treatment typically takes about three or four hours.
Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...
January 28, 2026 
Jan. 27, 2026 — Siemens Healthineers and World Athletics have joined forces to inform medical teams how point-of-care ...
January 27, 2026 
Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...
January 27, 2026 
Jan. 26, 2026 — Researchers at the University of Arizona were awarded up to $1.8 million by the Advanced Research ...
January 26, 2026 
Dec. 19, 2025 — Washington University in St. Louis (WashU) has been recognized as a Focused Ultrasound Center of ...
December 23, 2025 
Dec. 12, 2025 — Hyperfine, Inc. has announced that it has received FDA clearance for a new multi-direction diffusion ...
December 15, 2025 
Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...
December 10, 2025 
Healthcare has reached a critical juncture. The World Economic Forum estimates that global medical costs will see double ...
December 04, 2025 
Nov. 20, 2025 — Avatar Medical and Barco have launched Eonis Vision, marking a new evolution in how medical imaging is ...
November 20, 2025 
Nov. 19, 2025 — Royal Philips has announced an extended partnership with Cortechs.ai. Together, the companies will ...
November 19, 2025 